These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21600023)

  • 21. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of Constrained Optimization Methods in Health Services Research: Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force.
    Crown W; Buyukkaramikli N; Sir MY; Thokala P; Morton A; Marshall DA; Tosh JC; Ijzerman MJ; Padula WV; Pasupathy KS
    Value Health; 2018 Sep; 21(9):1019-1028. PubMed ID: 30224103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The net effect of alternative allocation ratios on recruitment time and trial cost.
    Vozdolska R; Sano M; Aisen P; Edland SD
    Clin Trials; 2009 Apr; 6(2):126-32. PubMed ID: 19342464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic approach to designing statistically powerful heteroscedastic 2 × 2 factorial studies while minimizing financial costs.
    Jan SL; Shieh G
    BMC Med Res Methodol; 2016 Aug; 16(1):114. PubMed ID: 27578357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Informing Balanced Investment in Services and Health Systems: A Case Study of Priority Setting for Tuberculosis Interventions in South Africa.
    Bozzani FM; Sumner T; Mudzengi D; Gomez GB; White R; Vassall A
    Value Health; 2020 Nov; 23(11):1462-1469. PubMed ID: 33127017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
    Colombini D; Occhipinti E
    Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-Effectiveness of Multifaceted Built Environment Interventions for Reducing Transmission of Pathogenic Bacteria in Healthcare Facilities.
    Squire MM; Igusa T; Siddiqui S; Sessel GK; Squire EN
    HERD; 2019 Apr; 12(2):147-161. PubMed ID: 30991849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individual health services.
    Schnell-Inderst P; Hunger T; Hintringer K; Schwarzer R; Seifert-Klauss VR; Gothe H; Wasem J; Siebert U
    GMS Health Technol Assess; 2011; 7():Doc05. PubMed ID: 21966301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-efficient assessment of biomechanical exposure in occupational groups, exemplified by posture observation and inclinometry.
    Trask C; Mathiassen SE; Wahlström J; Forsman M
    Scand J Work Environ Health; 2014 May; 40(3):252-65. PubMed ID: 24469242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endovascular laser therapy for varicose veins: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(6):1-92. PubMed ID: 23074409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost/variance optimization for human exposure assessment studies.
    Whitmore RW; Pellizzari ED; Zelon HS; Michael LC; Quackenboss JJ
    J Expo Anal Environ Epidemiol; 2005 Nov; 15(6):464-72. PubMed ID: 15886716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-efficient higher-order crossover designs in comparative bioavailability studies.
    Zhou J; Yuan Y; Reynolds R; Raber S; Li Y
    Clin Pharmacokinet; 2006; 45(6):623-32. PubMed ID: 16719543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study design for exposure assessment in epidemiological studies.
    Armstrong B
    Sci Total Environ; 1995 Jun; 168(2):187-94. PubMed ID: 7481737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal design of longitudinal data analysis using generalized estimating equation models.
    Liu J; Colditz GA
    Biom J; 2017 Mar; 59(2):315-330. PubMed ID: 27878852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sampling over time: developing a cost effective and precise exposure assessment program.
    Shukla R; Luo J; Lemasters GK; Grinshpun SA; Martuzevicius D
    J Environ Monit; 2005 Jun; 7(6):603-7. PubMed ID: 15931422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weighing gains and losses in criterion validity studies with test-based enrollment.
    Reichenheim ME
    J Clin Epidemiol; 2003 Oct; 56(10):983-8. PubMed ID: 14568630
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.